Millennium Management
GRTX

Millennium Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Millennium Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-76,630
Closed -$10.7K – 6735
2024
Q1 		$10.7K Buy
+76,630
New +$15.1K ﹤0.01% 5919
2023
Q3 		– Sell
-125,640
Closed -$392K – 6708
2023
Q2 		$392K Buy
+125,640
New +$374K ﹤0.01% 4717
2022
Q3 		– Sell
-18,530
Closed -$24K – 7622
2022
Q2 		$24K Sell
18,530
-38,051
-67% -$65.2K ﹤0.01% 6443
2022
Q1 		$135K Sell
56,581
-97,857
-63% -$255K ﹤0.01% 6013
2021
Q4 		$709K Buy
154,438
+117,110
+314% +$387K ﹤0.01% 4737
2021
Q3 		$302K Sell
37,328
-81,220
-69% -$696K ﹤0.01% 5814
2021
Q2 		$1.17M Buy
+118,548
New +$963K ﹤0.01% 4526
2021
Q1 		– Sell
-40,199
Closed -$411K – 6615
2020
Q4 		$411K Buy
40,199
+12,317
+44% +$135K ﹤0.01% 4350
2020
Q3 		$252 Buy
+27,882
New +$221K ﹤0.01% 3952
2020
Q1 		– Sell
-50,472
Closed -$664K – 4650
2019
Q4 		$664K Buy
+50,472
New +$615K ﹤0.01% 3206

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Millennium Management's GRTX Position: Q2 2024 in Review

Millennium Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 76,630 shares — an estimated $10.7K sold.

Millennium Management first reported a position in GRTX in Q4 2019 and held it in 10 quarters. The position peaked at $1.17M in Q2 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Millennium Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 76,630 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $10.7K.
  • Millennium Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Millennium Management's Galera Therapeutics, Inc. Common Stock position peaked at $1.17M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.